POS0489 CCL24 Serum Concentration Correlates With Disease Activity And Worse Prognosis In Diffuse Cutaneous Ssc: A Promising Biological Target To Prevent Disease Progression

Segal Salto, M., Mor, A. and Del Galdo, F. orcid.org/0000-0002-8528-2283 (2022) POS0489 CCL24 Serum Concentration Correlates With Disease Activity And Worse Prognosis In Diffuse Cutaneous Ssc: A Promising Biological Target To Prevent Disease Progression. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , 499.1-49499.

Metadata

Item Type: Proceedings Paper
Authors/Creators:
Dates:
  • Published: June 2022
  • Published (online): 23 May 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 25 Sep 2024 12:31
Last Modified: 26 Sep 2024 13:21
Status: Published
Publisher: BMJ
Identification Number: 10.1136/annrheumdis-2022-eular.4810
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)